Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Harris

Showing results (341-350 of 398) with videos related to

Pageof 40
Sort By:
Plos Neglected Tropical Diseases|July 31, 2018
Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemicYi Tan, Brett E Pickett, Susmita Shrivastava, et al.
Journal of Clinical Microbiology|August 28, 2024
Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccinationFreddy A Medina, Frances Vila, Laura E Adams, et al.
Science Translational Medicine|February 19, 2025
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Cell Reports|December 26, 2019
Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue DiseaseYuan Tian, Grégory Seumois, Luzia M De-Oliveira-Pinto, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Comparison of the Sensitivity and Specificity of Commercial Anti-Dengue Virus IgG Tests to Identify Persons Eligible for Dengue VaccinationFreddy A Medina, Frances Vila, Laura E Adams, et al.
Plos Neglected Tropical Diseases|September 9, 2010
Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosisMaria G Guzman, Thomas Jaenisch, Roger Gaczkowski, et al.
Tropical Medicine & International Health : TM & IH|January 10, 2019
The decline of dengue in the Americas in 2017: discussion of multiple hypothesesFreddy Perez, Anthony Llau, Gamaliel Gutierrez, et al.
Cell Host & Microbe|June 18, 2013
Convergent antibody signatures in human denguePoornima Parameswaran, Yi Liu, Krishna M Roskin, et al.
Cell Host & Microbe|November 1, 2023
Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccinationJennifer E Munt, Sandra Henein, Cameron Adams, et al.
Ebiomedicine|May 10, 2017
The Role of Heterotypic DENV-specific CD8<sup>+</sup>T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus InfectionLaura B Talarico, Juan P Batalle, Alana B Byrne, et al.
Pageof 40

Showing results (341-350 of 398) with videos related to

Sort By:
Pageof 40
Plos Neglected Tropical Diseases|July 31, 2018
Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemicYi Tan, Brett E Pickett, Susmita Shrivastava, et al.
Journal of Clinical Microbiology|August 28, 2024
Comparison of the sensitivity and specificity of commercial anti-dengue virus IgG tests to identify persons eligible for dengue vaccinationFreddy A Medina, Frances Vila, Laura E Adams, et al.
Science Translational Medicine|February 19, 2025
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Cell Reports|December 26, 2019
Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue DiseaseYuan Tian, Grégory Seumois, Luzia M De-Oliveira-Pinto, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Comparison of the Sensitivity and Specificity of Commercial Anti-Dengue Virus IgG Tests to Identify Persons Eligible for Dengue VaccinationFreddy A Medina, Frances Vila, Laura E Adams, et al.
Plos Neglected Tropical Diseases|September 9, 2010
Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosisMaria G Guzman, Thomas Jaenisch, Roger Gaczkowski, et al.
Tropical Medicine & International Health : TM & IH|January 10, 2019
The decline of dengue in the Americas in 2017: discussion of multiple hypothesesFreddy Perez, Anthony Llau, Gamaliel Gutierrez, et al.
Cell Host & Microbe|June 18, 2013
Convergent antibody signatures in human denguePoornima Parameswaran, Yi Liu, Krishna M Roskin, et al.
Cell Host & Microbe|November 1, 2023
Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccinationJennifer E Munt, Sandra Henein, Cameron Adams, et al.
Ebiomedicine|May 10, 2017
The Role of Heterotypic DENV-specific CD8<sup>+</sup>T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus InfectionLaura B Talarico, Juan P Batalle, Alana B Byrne, et al.
Pageof 40